Tibosovo (ivosidenib) is a prescription medicine used to treat adults with an IDH1 mutation who have:
- Acute myeloid leukemia (AML) that is either newly-diagnosed or relapsed/refractory, or
- Locally advanced or metastatic bile duct cancer (cholangiocarcinoma)
